Table 3.
Genotype frequencies within warfarin metabolism and sensitivity groups
| Warfarin metabolism (CYP2C9)
| ||
|---|---|---|
| Metabolism | Genotype | Genotype frequency |
|
| ||
| Normal | *1/*1 | 81.01% (n= 123) |
| Intermediate | *1/*2, *1/*3 | 17.03% (n=26) |
| Poor | *2/*2 *2/*3 | 1.96% (n=3) |
|
Warfarin sensitivity (VKORCI/CYP2C9) | ||
| Sensitivity | Genotype | Genotype frequency |
| Normal | GG/*1*1, GG/*1*2, GA/*1*1 | 68.4% (n= 104) |
| Moderate | GG/*1*3, GG/*2*2, GG/*2*3, GA/*1*2, GA/*1*3, GA/2*2, AA/*1*1, AA/*1*2 | 28.9% (n=44) |
| High | GG/*3*3, GA/*2*3, GA/*3*3, AA/*1*3, AA/*2*2, AA/*2*3, AA/*3*3 | 2.6% (n=4) |